Latest Breaking News On - Prescription drug event - Page 1 : vimarsana.com

CMS Updates Guidance On The Medicare Prescription Payment Plan: What Part D Plans Should Be Doing Now - Healthcare

The Centers for Medicare & Medicaid Services updated its guidance on the Inflation Reduction Act of 2022's Medicare Prescription Payment Plan with its release of the Final Part One Guidance on February 29, 2024, and the Draft Part Two Guidance on February 15, 2024.

CMS Updates Guidance on the Medicare Prescription Payment Plan: What Part D Plans Should Be Doing Now | Wiley Rein LLP

The Centers for Medicare & Medicaid Services (CMS) updated its guidance on the Inflation Reduction Act of 2022’s (P.L. 117-169) (IRA) Medicare Prescription Payment Plan (M3P) with its...

CMS Implementing Inflation Reduction Act for Drug Pricing

Medicare Program; Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications

Medicare Drug Price Negotiation Program Final Guidance - Life Sciences, Biotechnology & Nanotechnology

On June 30, 2023, the Centers for Medicare and Medicaid Services (CMS) released its much-anticipated final guidance ("Final Guidance") for the Medicare Drug Price Negotiation Program...

CMS provides reporting guidance to Medicare Part D sponsors

CMS has provided Prescription Drug Event (PDE) reporting guidance to Medicare Part D sponsors regarding rebates and other price concessions at the point of sale. This guidance is applicable in all phases of the Part D benefit, including the coverage gap. PDE is the summary record that a prescription drug plan sponsor needs to submit to CMS after every time a beneficiary fills a prescription under Medicare Part D.

Contract Year 2023 Part D Proposed Rule Released: Changes To 'Negotiated Price' Would Require Potential DIR Fees at the Point of Sale | Arent Fox

The Centers for Medicare & Medicaid Services (CMS) published the proposed Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug...